InvestorsHub Logo
Followers 155
Posts 2649
Boards Moderated 0
Alias Born 01/29/2004

Re: BIOChecker4 post# 352973

Tuesday, 03/01/2022 5:43:38 PM

Tuesday, March 01, 2022 5:43:38 PM

Post# of 462979
Mothers will move their daughters to blarcamesine.

They [Neuren/Acadia, with Trofinetide] will be first to market and enjoy first-mover advantages for a considerable period of time.

But the “moving” side effects of the drug will prompt mothers of Rett syndrome girls to request prescriptions for blarcamesine, once it’s available. A moving side effect of Trofinetide is diarrhea. Blarcamesine does not induce intestinal mobility or activity.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News